Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 8
Results: 18
Erratum.
- Published in:
- 2023
- Publication type:
- Correction Notice
Review of Ruxolitinib for Treatment of Non-Segmental Vitiligo.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 948, doi. 10.1177/10600280221143748
- By:
- Publication type:
- Article
A CYP3A4 Drug-Drug Interaction Between Nirmatrelvir/Ritonavir and Nifedipine Leading to Edema, Oliguria, and Acute Kidney Injury: A Case Report.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 991, doi. 10.1177/10600280221143131
- By:
- Publication type:
- Article
Efficacy and Safety of Vancomycin Bayesian-Estimated Area Under the Curve Versus Trough-Based Dosing.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 931, doi. 10.1177/10600280221141402
- By:
- Publication type:
- Article
Gaps in Evidence-based Treatment of Concurrent Attention Deficit Hyperactivity Disorder and Opioid Use Disorder: A Scoping Review.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 978, doi. 10.1177/10600280221141065
- By:
- Publication type:
- Article
Efficacy and Safety of Sacubitril/Valsartan Compared With ACEI/ARB on Health-Related Quality of Life in Heart Failure Patients: A Meta-Analysis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 907, doi. 10.1177/10600280221140575
- By:
- Publication type:
- Article
Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 956, doi. 10.1177/10600280221140480
- By:
- Publication type:
- Article
The Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients Hospitalized With Acute Kidney Injury.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 925, doi. 10.1177/10600280221139248
- By:
- Publication type:
- Article
Practical Challenges With the Implementation of First-Order Pharmacokinetic Analytic Equations for AUC Monitoring for Vancomycin.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 997, doi. 10.1177/10600280221139242
- By:
- Publication type:
- Article
Comparison of Open-Access, Trough-Only Online Calculators Versus Trapezoidal Method for Calculation of Vancomycin Area Under the Curve (AUC).
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 940, doi. 10.1177/10600280221138867
- By:
- Publication type:
- Article
Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease–Associated Hemolysis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 970, doi. 10.1177/10600280221138802
- By:
- Publication type:
- Article
A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 966, doi. 10.1177/10600280221137750
- By:
- Publication type:
- Article
Evaluation of Bleeding in Orthopedic Surgery With Perioperative Use of Serotonergic Antidepressants.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 885, doi. 10.1177/10600280221134108
- By:
- Publication type:
- Article
Comment: "Co-Prescribing of Central Nervous System-Active Medications for COPD Patients: Impact on Emergency Room Visits and Hospitalization".
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 993, doi. 10.1177/10600280221136254
- By:
- Publication type:
- Article
Author's Reply "Considerations Regarding a Cohort Study on Concomitant Use of Central Nervous System-Active Medications in Patients With COPD".
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 995, doi. 10.1177/10600280221136243
- By:
- Publication type:
- Article
Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 892, doi. 10.1177/10600280221134643
- By:
- Publication type:
- Article
Clinical Outcomes of Oral Zinc Therapy in Hepatic Encephalopathy Treatment.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 899, doi. 10.1177/10600280221134283
- By:
- Publication type:
- Article
Proportion of Patients on Warfarin Therapy Who Are Eligible for Conversion to a Direct Oral Anticoagulant in the Setting of COVID-19.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 918, doi. 10.1177/10600280221136874
- By:
- Publication type:
- Article